not tagged
not tagged
[]
 presenting nlg-lbc-06 of high risk lbcl showing da-epoch-r with comparable outcomes for high-risk biological groups compared to historical groups; worse outcomes high ctdna burden and tp53 at diagnosis - may be responsible for low risk pts who do worse #icml23 #17icml 
Heme/Onc fellow @UCCancerCenter interested in aggressive lymphoma, novel therapeutics, and cellular therapies #lymsm #TcellRx. Views are my own.